Barely Significant
← all excerpts

Cardiogenic Shock Management and Research: Past, Present, and Future Outlook.

US Cardiol · 2022 · PMC11588188 · PMID 39600845

1
hedged sentence
closest p
boldest claim

The sentences

presented the IMPRESS study, the first prospective multicenter trial comparing Impella CP (n=24) with IABP (n=24).[ 47 ] This study, again, showed no significant difference in mortality rate (50% versus 46%; p=0.92); differences in bleeding complications also failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.